Zentalis Pharmaceuticals Inc (ZNTL)
11.77
-0.80
(-6.36%)
USD |
NASDAQ |
Apr 24, 16:00
11.77
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Shareholders Equity (Quarterly): 437.28M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 437.28M |
| September 30, 2023 | 481.77M |
| June 30, 2023 | 523.14M |
| March 31, 2023 | 385.49M |
| December 31, 2022 | 433.80M |
| September 30, 2022 | 428.50M |
| June 30, 2022 | 472.49M |
| March 31, 2022 | 315.30M |
| December 31, 2021 | 363.95M |
| Date | Value |
|---|---|
| September 30, 2021 | 393.43M |
| June 30, 2021 | 223.84M |
| March 31, 2021 | 268.39M |
| December 31, 2020 | 308.58M |
| September 30, 2020 | 341.06M |
| June 30, 2020 | 213.22M |
| March 31, 2020 | -95.90M |
| December 31, 2019 | -80.11M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-95.90M
Minimum
Mar 2020
523.14M
Maximum
Jun 2023
318.48M
Average
363.95M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| Revolution Medicines Inc | 1.826B |
| Day One Biopharmaceuticals Inc | 346.54M |
| Perspective Therapeutics Inc | 75.18M |
| Electromed Inc | 40.34M |
| Xtant Medical Holdings Inc | 51.35M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 551.69M |
| Total Liabilities (Quarterly) | 114.30M |